M. Thomas
Impact in
- Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Oncology 11
- Lung Cancer Research Studies 8
-
- Lung Cancer Treatments and Mutations 5
- Lung Cancer Diagnosis and Treatment 2
- Co-authors
- C Jacquillat (1 shared paper)Pierre Boivin (1 shared paper)Ariane Auquier (1 shared paper)M. Monconduit (1 shared paper)G Vaugier (1 shared paper)Claude Lesty (1 shared paper)F Grémy (1 shared paper)G Potron (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)European Journal of Cancer (1 paper)Lung Cancer (1 paper)Annals of Oncology (1 paper)Cancer (1 paper)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
M. Thomas
19 papers receiving 1.5k citations
M. Thomas's Hit Papers
Peers
Comparison fields: 5 of 58
- Genetics 1.2k
- Pathology and Forensic Medicine 773
- Immunology 507
- Hematology 161
- Oncology 222
Countries citing papers authored by M. Thomas
This map shows the geographic impact of M. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Thomas more than expected).
Fields of papers citing papers by M. Thomas
This network shows the impact of papers produced by M. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Thomas. The network helps show where M. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis Hit paper breakdown → | 1981 | 1287 |
| 2 | 1992 | 74 | |
| 3 | Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. | 1999 | 40 |
| 4 | 1998 | 37 | |
| 5 | De Garengeot hernia. | 2009 | 31 |
| 6 | 2011 | 17 | |
| 7 | 1989 | 11 | |
| 8 | 1994 | 8 | |
| 9 | 2004 | 6 | |
| 10 | 2005 | 6 | |
| 11 | Carboplatin plus oral etoposide in the management of advanced, non-small cell lung cancer: preliminary results of a Vanderbilt trial. | 1992 | 5 |
| 12 | 2002 | 4 | |
| 13 | 1997 | 3 | |
| 14 | 2005 | 3 | |
| 15 | 2004 | 3 | |
| 16 | 1974 | 1 | |
| 17 | 2008 | 1 | |
| 18 | [Pilonidal cysts. 161 operated cases (author's transl)]. | 1977 | 1 |
| 19 | 2014 | 1 | |
| 20 | 2025 | 0 |
About M. Thomas
M. Thomas is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Genetics, having authored 20 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (8 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Neuroendocrine Tumor Research Advances (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Head and Neck Cancer Studies (1 paper). The work is most often cited by research in Genetics (1.2k citations), Pathology and Forensic Medicine (773 citations), Immunology (507 citations), Hematology (161 citations) and Oncology (222 citations). M. Thomas has collaborated with scholars based in United States, Germany and France. Frequent co-authors include C Jacquillat, Pierre Boivin, Ariane Auquier, M. Monconduit, G Vaugier, Claude Lesty, F Grémy, G Potron, H Piguet and J. Goasguen. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Lung Cancer, Annals of Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.